Pharma News

AstraZeneca and Oxford University’s COVID-19 vaccine has similar efficacy against the British coronavirus version as it does to the previously circulating variants, the university said on Friday. The version, first identified in Kent, southern England, is more readily transmissible, prompting many countries to limit travel to Britain. It also led to a spike in infections …

Johnson & Johnson said it has asked US health regulators to authorize its single-dose COVID-19 vaccine for emergency use, and it’ll apply to European authorities in coming weeks. The drugmaker’s application to the U.S. Food and Drug Administration (FDA) follows its Jan. 29 report where it said the vaccine had a 66% rate of preventing …

Bangladesh’s Beximco Pharmaceuticals Ltd said on Thursday the Serum Institute of India (SII) had delayed the first supplies of a COVID-19 vaccine for personal sale, instead prioritising government immunisation campaigns. Beximco is Bangladesh’s exclusive distributor of the Oxford University-AstraZeneca shot that SII, the world’s biggest vaccine maker, is producing in bulk for low- and medium-income …

Pfizer Inc on Tuesday forecast sales of about $15 billion from the coronavirus vaccine that it is making along with German spouse BioNTech and raised its full-year profit forecast. The company said it expects total 2021 earnings of between $59.4 billion and $61.4 billion. The vaccine was among the first to be authorized for emergency …

The recently hosted CPhI & P-MEC China 2020 – organized by Informa Markets and CCCMHPIE and co-organized by Shanghai Sinoexpo Informa Markets International Exhibition Co., Ltd. – attracted a remarkable 46,157 visits of professional pharma visitors, including 5,105 international attendees taking part online. The hybrid event has helped stimulate renewed growth and partnerships across the …

Pharmaceutical company AstraZeneca has agreed to provide 9 million additional doses of its coronavirus vaccine into the European Union during the first quarter, the bloc’s executive arm said Sunday. The new target of 40 million doses by the end of March is still only half what the British-Swedish firm had originally aimed for before it …

Johnson & Johnson’s long-awaited vaccine seems to protect against COVID-19 with just 1 shot — not as strong as some two-shot rivals but still potentially helpful for a world in dire need of more doses. J&J said Friday that in the U.S. and seven other nations, the single-shot vaccine was 66% effective overall at preventing …

India; January 27, 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ) referred to as “Cipla” today announced that it has set up a 30 MW solar group captive project in Tuljapur, Maharashtra. Spread across 115 acres, the solar project has been commissioned in partnership with AMP Energy India, and is one of the largest solar …

Nottingham, UK – January 25th, 2021 – Life Science Newswire – Albumedix Ltd. (‘Albumedix’), the world leader in recombinant human albumin (rHA), announced the submission of Drug Master Files (DMFs) to the Pharmaceutical and Medical Device Agency (PMDA) in Japan. Albumedix has submitted DMFs for two of their products in order to further support customers …